ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$195.16+0.14 (+0.07%)
Close on Nov 18, 2026Market cap $14.94BP/E 33.6Yield –
ICON net income
Net income is the profit left for shareholders after every expense, interest and tax.
ICON's net income for the twelve months ending Sep 30, 2026 was $448.66M, up 19.7% year over year. For fiscal 2025 it was $229.34M, down 69.0% from the year before. Over ten years it grew -0.4% a year on average. The highest annual figure on record is $739.13M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $229.34M | -69.0% |
| FY2024 | Dec 31, 2024 | $739.13M | +33.4% |
| FY2023 | Dec 31, 2023 | $554.21M | +9.7% |
| FY2022 | Dec 31, 2022 | $505.30M | +229.9% |
| FY2021 | Dec 31, 2021 | $153.19M | -53.9% |
| FY2020 | Dec 31, 2020 | $332.33M | -11.1% |
| FY2019 | Dec 31, 2019 | $373.99M | +15.9% |
| FY2018 | Dec 31, 2018 | $322.66M | +14.6% |
| FY2017 | Dec 31, 2017 | $281.49M | +7.4% |
| FY2016 | Dec 31, 2016 | $262.18M | +9.5% |
| FY2015 | Dec 31, 2015 | $239.54M | +38.9% |
| FY2014 | Dec 31, 2014 | $172.47M | +67.8% |
| FY2013 | Dec 31, 2013 | $102.81M | +85.5% |
| FY2012 | Dec 31, 2012 | $55.42M | +142.2% |
| FY2011 | Dec 31, 2011 | $22.88M | -73.7% |
| FY2010 | Dec 31, 2010 | $87.07M | -7.7% |
| FY2009 | Dec 31, 2009 | $94.30M | +20.7% |
| FY2008 | Dec 31, 2008 | $78.12M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $122.13M | – |
| Q2 FY2026 | Jun 30, 2026 | $72.58M | -64.3% |
| Q1 FY2026 | Mar 31, 2026 | $104.75M | -34.9% |
| Q4 FY2025 | Dec 31, 2025 | $149.19M | -49.4% |
| Q3 FY2025 | Sep 30, 2025 | -$284.18M | -233.3% |
| Q2 FY2025 | Jun 30, 2025 | $203.52M | +145.9% |
| Q1 FY2025 | Mar 31, 2025 | $160.81M | +8.4% |
| Q4 FY2024 | Dec 31, 2024 | $294.75M | +60.7% |
| Q3 FY2024 | Sep 30, 2024 | $213.27M | +38.6% |
| Q2 FY2024 | Jun 30, 2024 | $82.78M | -23.4% |
| Q1 FY2024 | Mar 31, 2024 | $148.34M | +36.2% |
| Q4 FY2023 | Dec 31, 2023 | $183.39M | +56.1% |
| Q3 FY2023 | Sep 30, 2023 | $153.90M | -3.9% |
| Q2 FY2023 | Jun 30, 2023 | $108.05M | -6.6% |
| Q1 FY2023 | Mar 31, 2023 | $108.88M | -2.8% |
| Q4 FY2022 | Dec 31, 2022 | $117.45M | +53.6% |
| Q3 FY2022 | Sep 30, 2022 | $160.15M | – |
| Q2 FY2022 | Jun 30, 2022 | $115.73M | +56.7% |
| Q1 FY2022 | Mar 31, 2022 | $111.97M | +15.3% |
| Q4 FY2021 | Dec 31, 2021 | $76.47M | -24.5% |
| Q3 FY2021 | Sep 30, 2021 | -$94.27M | -202.9% |
| Q2 FY2021 | Jun 30, 2021 | $73.87M | +54.7% |
| Q1 FY2021 | Mar 31, 2021 | $97.12M | +5.9% |
| Q4 FY2020 | Dec 31, 2020 | $101.23M | +2.2% |
| Q3 FY2020 | Sep 30, 2020 | $91.64M | -3.4% |
| Q2 FY2020 | Jun 30, 2020 | $47.76M | -48.0% |
| Q1 FY2020 | Mar 31, 2020 | $91.70M | +3.8% |
| Q4 FY2019 | Dec 31, 2019 | $99.01M | +12.3% |
| Q3 FY2019 | Sep 30, 2019 | $94.83M | +12.2% |
| Q2 FY2019 | Jun 30, 2019 | $91.86M | +27.8% |
| Q1 FY2019 | Mar 31, 2019 | $88.30M | +13.1% |
| Q4 FY2018 | Dec 31, 2018 | $88.16M | +24.0% |
| Q3 FY2018 | Sep 30, 2018 | $84.53M | +14.0% |
| Q2 FY2018 | Jun 30, 2018 | $71.87M | +10.9% |
| Q1 FY2018 | Mar 31, 2018 | $78.10M | +9.4% |
| Q4 FY2017 | Dec 31, 2017 | $71.11M | -4.2% |
| Q3 FY2017 | Sep 30, 2017 | $74.15M | – |
| Q2 FY2017 | Jun 30, 2017 | $64.82M | – |
| Q1 FY2017 | Mar 31, 2017 | $71.41M | – |
| Q4 FY2016 | Dec 31, 2016 | $74.26M | – |
See a number that looks wrong?